Apollomics, Inc. (NASDAQ:APLMW) Short Interest Update

Apollomics, Inc. (NASDAQ:APLMW) saw a significant increase in short interest in the month of January. As of January 15th, there was short interest totalling 18,900 shares, an increase of 2,600.0% from the December 31st total of 700 shares. Based on an average daily volume of 82,200 shares, the short-interest ratio is presently 0.2 days.

Apollomics Stock Performance

Shares of NASDAQ APLMW traded up $0.00 during midday trading on Friday, hitting $0.01. The company’s stock had a trading volume of 600 shares, compared to its average volume of 19,339. The stock has a fifty day moving average price of $0.01 and a 200 day moving average price of $0.01. Apollomics has a one year low of $0.01 and a one year high of $0.04.

Apollomics Company Profile

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.